Related Experiment Video
Updated: May 21, 2026
11:36
A Cell Culture Model for Studying the Role of Neuron-Glia Interactions in Ischemia
Published on: November 14, 2020
Neuroprotection by GDNF in the ischemic brain
Emília P Duarte1, Michele Curcio, Lorella M Canzoniero
1CNC - Center for Neuroscience and Cell Biology, University of Coimbra, Largo Marquês de Pombal, Coimbra, Portugal.
Growth Factors (Chur, Switzerland)
|June 8, 2012
Summary
Glial cell line-derived neurotrophic factor (GDNF) protects neurons in brain ischemia models. This neurotrophic factor shows promise for treating stroke, even when given after injury.
Area of Science:
- Neuroscience
- Molecular Biology
- Cell Biology
Background:
- Glial cell line-derived neurotrophic factor (GDNF) initially identified as a survival factor for dopaminergic neurons.
- GDNF also acts as a trophic factor for various central and peripheral nervous system neurons.
- GDNF signaling involves interaction with GDNF family receptor-α1 and potentially Ret tyrosine receptors or neural cell adhesion molecule.
Purpose of the Study:
- To review the neuroprotective effects of GDNF in experimental models of brain ischemia.
- To discuss various administration strategies for GDNF in ischemic conditions.
- To explore the mechanisms underlying GDNF-mediated neuroprotection.
Main Methods:
- Review of existing literature on GDNF and its role in neuroprotection.
- Analysis of experimental models of focal and global brain ischemia.
- Examination of different GDNF delivery methods, including local administration, viral vectors, and cell transplantation.
Main Results:
- Exogenous GDNF demonstrates neuroprotective effects in various experimental models of brain ischemia.
- GDNF administration, via multiple strategies, promotes cell survival, neurite outgrowth, and synaptogenesis.
- Neuroprotection by GDNF has been observed even when treatment is initiated after the ischemic injury has occurred.
Conclusions:
- GDNF is a potent neurotrophic factor with significant neuroprotective capabilities against ischemic brain injury.
- Diverse delivery methods can be employed to harness GDNF's therapeutic potential in stroke treatment.
- The timing of GDNF administration is flexible, offering therapeutic opportunities even in post-injury scenarios.
Related Concept Videos
01:15Neurogenesis and Regeneration of Nervous Tissue
In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...
00:49The Blood-brain Barrier
Overview
01:15Ischemic Stroke ll: Pathophysiology
An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...